Personal profile


Jan Hansel is an NIHR Academic Clinical Fellow in Intensive Care Medicine at The University of Manchester and Manchester University NHS Foundation Trust. His research focuses on precision methods in sepsis antimicrobial therapy and airway management.

He graduated from The University of Maribor (Slovenia, 2015) and started his clinical training in Reykjavík, Icealnd. In 2019 he started training in Anaesthetics in Health Education North West, and is currently a dual trainee in Intensive Care Medicine and Anaesthetics in the North West. He started his NIHR Academic Clinical Fellowship in 2021 and is due to compelete it in 2024.

He has published over 35 peer reviewed publications and has an H-index of 8 on Google Scholar. He was the principal author on an impactful Cochrane systematic review looking at devices used for tracheal intubation in adults in 2022, which has since been cited more than 200 times and has informed multiple clinical practice guidelines. He is a member of the steering committee for the Airway Terminology and Outcome Measures group, which is funded by the Association of Anaesthetists and the journal Anaesthesia through the National Insitute of Academic Anaesthesia. He is a regular peer reviewer for BMC Medical Education, BJA, JICS, BMJ Open.

He is the principal investigator of the NIHR Manchester Biomedical Research Centre (BRC) funded study TDM-TIME looking at timing of therapeutic drug monitoring of beta-lactam antimicrobials in critical care. He has received a New Investigator Award for this study from the Intensive Care Society. He is actively involved in the Trainee Research in Intensive Care (TRIC) network in the UK, and has helped deliver a number of multicentre projects.

Research interests

  • Precision methods in sepsis
  • Pharmacokinetics of beta-lactam antimicrobials in critical illness
  • Airway management
  • Clinical trials
  • Evidence synthesis methodology
  • Core outcome sets

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Master of Research, Pharmacokinetic variability of beta-lactam antibiotics in critically ill adults: a systematic review of population pharmacokinetic studies, The University of Manchester

2021Dec 2023

Award Date: 12 Dec 2023

Areas of expertise

  • RM Therapeutics. Pharmacology
  • R Medicine (General)


  • sepsis
  • pharmacokinetics
  • immunology
  • antimicrobial resistance
  • therapeutic drug monitoring


Dive into the research topics where Jan Hansel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or